CME Cme Group Inc

  1. Stocks
  2. Financial Services
  3. NASDAQ: CME

Price (delayed)

$206.13

Market cap

$74B

P/E Ratio

35.06

Dividend/share

$3.45

EPS

$5.88

Enterprise value

$162.59B

Sector: Financial Services
Industry: Financial Data & Stock Exchanges
Website: https://www.cmegroup.com/

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights

The debt has surged by 121% year-on-year
CME's P/E is 36% above its 5-year quarterly average of 25.7 and 28% above its last 4 quarters average of 27.3

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359M
Market cap
$74B
Enterprise value
$162.59B
Valuations
Price to earnings (P/E)
35.06
Price to book (P/B)
2.81
Price to sales (P/S)
15.1
EV/EBIT
56.32
EV/EBITDA
48.51
EV/Sales
33.29
Earnings
Revenue
$4.88B
EBIT
$2.89B
EBITDA
$3.35B
Free cash flow
$2.52B
Per share
EPS
$5.88
Free cash flow per share
$7.04
Book value per share
$73.32
Revenue per share
$13.65
TBVPS
$256.65
Balance sheet
Total assets
$124.66B
Total liabilities
$98.31B
Debt
$90.23B
Equity
$26.32B
Working capital
$1.09B
Liquidity
Debt to equity
3.43
Current ratio
1.01
Quick ratio
1.01
Net debt/EBITDA
26.43
Margins
EBITDA margin
68.6%
Gross margin
100%
Net margin
43.1%
Operating margin
54%
Efficiency
Return on assets
1.7%
Return on equity
7.9%
Return on invested capital
3%
Return on capital employed
7.9%
Return on sales
59.1%
Dividend
Dividend yield
1.67%
DPS
$3.45
Payout ratio
58.7%

CME stock price

How has the Cme Group stock price performed over time
Intraday
0%
1 week
-0.7%
1 month
3.1%
1 year
15.49%
YTD
13.23%
QTD
0.93%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.88B
Gross profit
$4.88B
Operating income
$2.64B
Net income
$2.11B
Gross margin
100%
Net margin
43.1%
The operating income is down by 2.2% QoQ
The company's net income fell by 2.1% QoQ

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
35.06
P/B
2.81
P/S
15.1
EV/EBIT
56.32
EV/EBITDA
48.51
EV/Sales
33.29
CME's P/E is 36% above its 5-year quarterly average of 25.7 and 28% above its last 4 quarters average of 27.3
The EPS has declined by 2.3% since the previous quarter
CME's price to book (P/B) is 22% higher than its 5-year quarterly average of 2.3 and 22% higher than its last 4 quarters average of 2.3
The equity has declined by 2.4% since the previous quarter
The P/S is 24% higher than the last 4 quarters average of 12.2 and 17% higher than the 5-year quarterly average of 12.9

Efficiency

How efficient is Cme Group business performance
The ROIC has plunged by 55% YoY and by 17% from the previous quarter
Cme Group's return on assets has decreased by 41% YoY and by 11% QoQ
The return on sales has declined by 2.3% since the previous quarter
Cme Group's return on equity has decreased by 2.5% QoQ

Dividends

What is CME's dividend history
DPS
$3.45
Dividend yield
1.67%
Payout ratio
58.7%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 27% more than its total liabilities
Cme Group's total liabilities has surged by 100% YoY
Cme Group's total assets has soared by 66% YoY
The debt has surged by 121% year-on-year
The debt to equity has soared by 120% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.